tm logo
Trademark Search
KYMAB

View On IC.GC.CA

KYMAB
REGISTERED

on 05 Jul 2024

Last Applicant/ Owned by

KYMAB LIMITED

The Bennet Building (B930),Babraham Research CampusCambridge CB22 3AT

GB

Serial Number

2168376 filed on 14th Sep 2021

Registration Number

TMA1242480 registered on 05th Jul 2024

Registration expiry Date

14th Sep 2031

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

KYMAB

Trademark usage description

pharmaceuticals, medical and veterinary preparations for the treatment and prevention of immunologic diseases and disorders namely, autoimmune disease Read More

Classification Information

Class [005]
Pharmaceuticals, medical and veterinary preparations for the treatment and prevention of immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology, rare autoimmune diseases and disorders, and blood disorders; sanitary preparations containing monoclonal antibodies for medical purposes; dietetic food and substances adapted for medical or veterinary use containing monoclonal antibodies; dietary supplements for human beings and animals containing monoclonal antibodies; dietary supplements containing monoclonal antibodies; pharmaceuticals preparations containing monoclonal antibodies for the treatment and prevention of immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology, rare autoimmune diseases and disorders, and blood disorders

Classification kind code

11

Class [042]
Scientific, medical and technological services, namely, scientific research, analysis and testing in the field of the treatment and prevention of immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology, rare autoimmune diseases and disorders, and blood disorders; medical research and development; design and development of medical technology for the treatment and prevention of immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology, rare autoimmune diseases and disorders, and blood disorders; industrial analysis and industrial research services in the field of immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology, rare autoimmune diseases and disorders, and blood disorders; design and development of computer hardware and software; design and development of hardware and software; clinical research in the field of immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology, rare autoimmune diseases and disorders, and blood disorders; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; clinical trials; clinical research in the field of immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology, rare autoimmune diseases and disorders, and blood disorders; conducting clinical trials for pharmaceutical products; scientific and medical screening and assaying in the field of genetic discovery, clinical development, antibodies and biological cells; chemical analysis; chemical research.

Classification kind code

11

Class [044]
Medical research services; medical laboratory services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; veterinary services; pharmaceutical consultation in the nature of pharmacy advice; pharmacy advice; medical and health services relating to antibodies, immunooncology, immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology, rare autoimmune diseases and disorders, and blood disorders; medical screening.

Classification kind code

11

Mark Details

Serial Number

2168376

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 08th Jun 2023		Search Recorded
Submitted for opposition 20
on 08th Jun 2023		Examiner's First Report
Submitted for opposition 223
on 08th Jun 2023		Total Provisional Refusal
Submitted for opposition 256
on 26th Dec 2022		Notification of Possible Opposition Sent
Submitted for opposition 48
on 30th Mar 2022		Agent Changed
Submitted for opposition 257
on 24th Feb 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 23rd Feb 2022		Created
Submitted for opposition 31
on 23rd Feb 2022		Formalized
Submitted for opposition 228
on 14th Sep 2021		International Registration
Submitted for opposition 30
on 14th Sep 2021		Filed